🔎 Trials Near Me

Gara Jalqabaatti › HIV › Georgia

Qorannoo klinikaalii HIV Georgia keessatti

Qorannoo 14 HIV f Georgia keessatti hirmaatuu jiru.

Magaalota Georgia keessatti

Takkalaa qorannoo (Ingiliffa)

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

  • Faebris Medical & Community Education, Atlanta
  • Grady Memorial Hospital, Atlanta
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07473778

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  • GSK Investigational Site, Decatur
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07650916

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

  • Metro Infectious Diseases Consultants L.L.C. ( Site 1509), Decatur
  • Mercer university, Department of internal medicine-Clinical Research ( Site 1512), Macon
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07266831

Screen2Prevent (S2P)

  • Emory Atlanta Adolescent Consortium, Atlanta
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 14 hanga 24 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07728123

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  • Atlanta ID Group, PC, Atlanta
  • Chatham County Health Department, Savannah
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT07682961

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  • GSK Investigational Site, Atlanta
  • GSK Investigational Site, Macon
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT07202546

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

  • Emory Children's Center ( Site 0103), Atlanta
Namoota walitti qabaa jiraSadarkaa 2
4 Weeks – 11 Years · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT04375800

Inflammation and Depression in People With HIV

  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital, Atlanta
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Cam-2026 · NCT05849038

Menopausal HT for Women Living With HIV (HoT)

  • The Ponce de Leon Center CRS (5802), Atlanta
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 40 hanga 60 · Dubartoota · Haaromfame 22-Cam-2026 · NCT06856174

Low Dose Naltrexone for Pain in Patients With HIV

  • Grady Memorial Hospital, Atlanta
  • Emory Midtown Hospital, Atlanta
  • Emory University Hospital, Atlanta
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 09-Elb-2026 · NCT05537935

Baricitinib for Reduction of HIV - CNS

  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital, Atlanta
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT05452564

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

  • Ponce de Leon Center CRS, Atlanta
  • The Hope Clinic of the Emory Vaccine Research Center; Emory University, Decatur
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT06796686

HIV Treatment Adherence Dose Determination Trial

  • University of Connecticut Field Site, Atlanta
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Hag-2025 · NCT04577313

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

  • GSK Investigational Site, Atlanta
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 6 hanga 12 · Saalaa hunda · Haaromfame 19-Ful-2024 · NCT05674656

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.